Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$4.11M Buy
39,068
+309
+0.8% +$29K 0.24% 79
2025
Q3
$3.25M Sell
38,759
-603
-2% -$49.7K 0.2% 92
2025
Q2
$3.12M Buy
39,362
+307
+0.8% +$24.4K 0.21% 92
2025
Q1
$3.51M Sell
39,055
-11,345
-23% -$1.06M 0.25% 79
2024
Q4
$5.01M Sell
50,400
-1,860
-4% -$192K 0.34% 68
2024
Q3
$5.93M Sell
52,260
-182
-0.3% -$21.6K 0.41% 56
2024
Q2
$6.49M Buy
52,442
+127
+0.2% +$16.4K 0.49% 45
2024
Q1
$6.9M Buy
52,315
+363
+0.7% +$44.7K 0.5% 46
2023
Q4
$5.66M Sell
51,952
-38
-0.1% -$3.94K 0.46% 49
2023
Q3
$5.35M Sell
51,990
-2,537
-5% -$273K 0.47% 49
2023
Q2
$6.29M Sell
54,527
-243
-0.4% -$27.6K 0.55% 41
2023
Q1
$5.83M Sell
54,770
-568
-1% -$61.3K 0.54% 42
2022
Q4
$6.14M Sell
55,338
-592
-1% -$60.5K 0.57% 42
2022
Q3
$4.82M Buy
55,930
+45,556
+439% +$4.07M 0.5% 47
2022
Q2
$946K Sell
10,374
-1,187
-10% -$105K 0.14% 82
2022
Q1
$948K Sell
11,561
-300
-3% -$23.7K 0.12% 94
2021
Q4
$909K Sell
11,861
-140
-1% -$11.2K 0.11% 100
2021
Q3
$901K Buy
12,001
+899
+8% +$68.4K 0.13% 96
2021
Q2
$864K Sell
11,102
-601
-5% -$44.7K 0.13% 99
2021
Q1
$861K Sell
11,703
-50,987
-81% -$3.76M 0.13% 98
2020
Q4
$4.89M Buy
62,690
+4,269
+7% +$326K 0.77% 37
2020
Q3
$4.62M Buy
58,421
+176
+0.3% +$13.8K 0.91% 30
2020
Q2
$4.3M Buy
58,245
+1,734
+3% +$131K 0.89% 30
2020
Q1
$4.15M Buy
56,511
+1,058
+2% +$83.2K 1.04% 30
2019
Q4
$4.81M Buy
55,453
+2,345
+4% +$193K 0.89% 28
2019
Q3
$4.27M Buy
53,108
+1,611
+3% +$129K 0.4% 43
2019
Q2
$4.12M Buy
51,497
+2,943
+6% +$225K 0.4% 44
2019
Q1
$3.85M Buy
48,554
+364
+0.8% +$27.2K 0.39% 43
2018
Q4
$3.51M Buy
48,190
+897
+2% +$63.3K 0.41% 41
2018
Q3
$3.2M Buy
47,293
+386
+0.8% +$24.6K 0.3% 51
2018
Q2
$2.72M Sell
46,907
-1,907
-4% -$108K 0.25% 59
2018
Q1
$2.54M Buy
48,814
+6,369
+15% +$344K 0.24% 57
2017
Q4
$2.28M Buy
+42,445
New +$2.35M 0.22% 69

Other funds holding MRK

Cadence Bank's MRK Position: Q4 2025 in Review

Cadence Bank increased its Merck (MRK) stake by 0.8% in Q4 2025, buying an estimated $29K and bringing the position to 39,068 shares worth $4.11M. The position accounts for 0.24% of the portfolio, ranked #79.

Cadence Bank first reported a position in MRK in Q4 2017 and has held it in 33 quarters since. The position peaked at $6.9M in Q1 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Cadence Bank held 39,068 shares of Merck worth $4.11M as of Q4 2025.
  • Cadence Bank bought 309 Merck shares in Q4 2025, an estimated $29K.
  • Merck made up 0.24% of Cadence Bank's portfolio in Q4 2025, its #79 holding.
  • Cadence Bank first reported a position in Merck in Q4 2017 and has held it in 33 quarters since.
  • Cadence Bank's Merck position peaked at $6.9M in Q1 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.